Business Wire

Pluto Labs' 'Strategic Efficiency' AI Outperforms Google & Anthropic Models at a Fraction of the Cost

Share

— Achieves decisive victory in key scientific benchmarks, delivering highly practical and experimentally testable ideas with unparalleled cost-efficiency. Global commercial launch slated for Q3 2025, leveraging an existing platform of 170,000 researchers.

In the global race to create an 'AI Scientist' capable of independent scientific discovery, Korean startup Pluto Labs is making significant waves. While tech giants like Google and Anthropic define competitive strength by sheer computing power, Pluto Labs introduces 'Scinapse AI,' a groundbreaking model that develops a more effective AI Scientist at just one-tenth of the usual computational cost, achieving overwhelming performance against top models in blind evaluations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715211709/en/

GRAPH: Scientific Idea Generation Performance Comparison - Scinapse AI vs. Google Gemini 2.5 Pro vs. Claude Opus 4 (Evaluation conducted by Pluto Labs)

Pluto Labs pioneers a 'Strategic Efficiency' architecture, mirroring how human scientists optimize research. Instead of brute-force computing (like Google's 'Co-scientist'), Scinapse AI smartly delegates inefficient tasks, such as sifting through vast data, to its existing Scinapse academic search system (used by 170,000 researchers). This allows the AI to focus exclusively on creative reasoning and generating new ideas, leading to unparalleled practicality and cost-efficiency.

Scinapse AI's superior performance was proven in blind evaluations judged by direct competitors' AI models (OpenAI O3, Anthropic's Claude 4 Opus, and Google's Gemini 2.5 Pro). Scinapse AI consistently ranked #1 in 'Plausibility' (how realistic and sound an idea is) and 'Testability' (how easily an idea can be experimentally validated) across 61 diverse scientific topics. This confirms Scinapse AI delivers "real scientific hypotheses that are practical to implement and can be experimentally validated within 3-5 years," a significant leap from 'plausible fiction' to 'actionable scientific research.'

Pluto Labs has developed a robust system to eliminate AI 'hallucinations' (false information), a critical barrier in scientific AI. All Scinapse AI ideas are strictly grounded in a database of 260 million academic papers. The system dynamically refines searches for highly accurate data and rigorously cross-references ideas against the database to guarantee genuine novelty, identifying truly new scientific insights. "It provides the most complete answer to the question that challenges researchers most: 'Is this idea truly new?'" said Professor Changshin Jo of POSTECH. "The AI completes a literature review in minutes that would take a human researcher days or weeks, and with higher accuracy. This is not just an idea-generation tool; it's an innovation that fundamentally changes the starting point of research planning."

With cumulative funding of 5 billion KRW (~$3.6M USD), Pluto Labs is uniquely positioned to disrupt the global 'AI Scientist' race. Its 'efficiency' and 'practicality' approach, combined with its established Scinapse platform, sets it apart. "The fact that a small Korean startup has proven superior to Google in an objective benchmark is more than just a technical achievement—it's a symbolic event for innovative leadership," said Simon Kim, CEO of Hashed. "It demonstrates that success in advanced AI can be achieved through creative problem-solving and strategic design, not just infinite capital. This is a significant milestone that points to the future direction for the global AI ecosystem, suggesting a new path for AI agent development." Scinapse AI is slated for official global launch in Q3 2025.

About Pluto Labs:

Pluto Labs is a Seoul-based Research Intelligence service company founded in 2019 that specializes in AI-powered scientific research tools. The company operates Scinapse, a comprehensive academic search platform used by over 170,000 researchers worldwide. Scinapse AI, launching in Q3 2025, is a next-generation AI scientist system that generates research ideas with high scientific validity through a hybrid AI architecture while maintaining cost efficiency. The company has raised a cumulative 5 billion KRW (~$3.6M USD) in funding from investors including Hashed, JB Investment, HG Initiative, and POSCO Investment. Pluto Labs is committed to leading global research innovation through accessible AI solutions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250715211709/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM31.8.2025 11:15:00 CEST | Press release

− Sustained Benefit of Vutrisiran Across Mortality, Cardiovascular Events, Quality of Life and Cardiac Biomarkers Observed Through Up to 48 Months, Including 12 Months from the Ongoing Open-Label Extension, Reinforce Potential as First-Line Treatment for ATTR-CM –− Vutrisiran, which Delivers Rapid Knockdown of Transthyretin, Reduced the Risk of Composite of All-Cause Mortality or First Cardiovascular Event by 37% in the Overall Population and 42% in the Monotherapy Group During the Same Period – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results of new analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic approved for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. Data from the 12-month follow-up of the ongoing open-label extension (OLE) period of HELIOS-B were presented during an oral session at the European Society of Card

WETEX Opens Broad Investment Horizons for International Companies31.8.2025 08:30:00 CEST | Press release

DEWA will organise the exhibition from 30 September to 2 October 2025 Under the directives of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and the patronage of HH Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Supreme Council of Energy, Dubai Electricity and Water Authority (DEWA) will organise the 27th edition of the Water, Energy, Technology and Environment Exhibition (WETEX) from 30 September to 2 October 2025 at the Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250830023664/en/ WETEX opens broad investment horizons for international companies (Photo: AETOSWire) WETEX embodies the UAE's pioneering position in clean and renewable energy and sustainability. It also supports Dubai's ambitious vision of a sustainable economy. The exhibition covers multiple areas including water, energy, smart cities, green mobility, artificial i

Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C30.8.2025 18:00:00 CEST | Press release

Initiation of the development of new oral triple combination tablets, aimed at improving adherence and outcomes in low-density lipoprotein cholesterol (LDL-C) management. Recent findings from MILOS and SANTORINI registries presented at ESC Congress 2025, highlight ongoing challenges in accurately assessing cardiovascular (CV) risk and helping patients reach LDL-C targets.1-5 Furthermore, data from a four-country cohort of the MILOS study support the real-world effectiveness and safety of bempedoic acid in both sexes.6 Simulation using SANTORINI data reveals the potential of improved LDL-C goal attainment with tailored oral combination therapy of statins, ezetimibe and bempedoic acid, in line with the latest 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.7,8 Daiichi Sankyo has a long-standing commitment to easing treatment of cardiovascular disease (CVD) and exploring new treatment options that improve CVD outcomes and treatment adherence. Daiich

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial30.8.2025 16:30:00 CEST | Press release

- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society of Cardiology Congress 2025 -- Zilebesiran Demonstrated Clinically Meaningful Reductions in Office Systolic Blood Pressure in Patients with Uncontrolled Hypertension and High Cardiovascular Risk at Month 3 Primary Endpoint, with Continuous Control Through Month 6 -- Zilebesiran Displayed Encouraging Safety When Combined with Two or More Antihypertensives -- Results Support Biannual Dosing Regimen and Inform Phase 3 Trial Design: Trial Expected to Initiate by Year-End 2025 -- Alnylam to Host Webcast Investor Event on August 30, 2025, at 1:00 pm ET (7:00 pm CEST) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) to evaluate the potential of zilebesiran to reduce the risk of major adverse cardiovascular events. This decision is informed by results from t

Andersen Consulting styrker sine kompetencer inden for virksomhedstransformation med Fabric29.8.2025 17:01:00 CEST | Pressemeddelelse

Andersen Consulting udvider sin platform gennem en samarbejdsaftale med Fabric, der er et strategisk designfirma, der arbejder med organisationer for at integrere bæredygtighed, forsyningskæder og menneske-centreret innovation på tværs af kultur og drift. Fabric blev grundlagt i Japan i 2021 og arbejder sammen med virksomheder og globale brands om at skabe regenerative forretningsmodeller sammen samt bæredygtige brandstrategier og fremtidssikrede produkter. Ved hjælp af strategiske designmetoder og designfilosofi skaber virksomheden indsigtsbaseret transformation på tværs af forsyningskæder, brand og HR. Fabric er kendt for sin systemtænkning og sit engagement i social og miljømæssig bæredygtighed og fremmer desuden digitale transformationsinitiativer, der integrerer bæredygtighed, humankapital og AI. "Fabric er skabt for at hjælpe virksomheder med at blomstre gennem regenerative relationer til mennesker, samfund og forbundne, levende systemer," sagde James Hollow, der er grundlægger a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye